SQI Diagnostics to Announce Fourth Quarter and Fiscal 2016 Results

Share on Linkedin

TORONTO, Nov. 23, 2016 /CNW/ – SQI Diagnostics Inc. (“SQI Diagnostics” or the “Company”) (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the fourth quarter and the fiscal year ended September 30, 2016 at 5:00 p.m. ET Tuesday, December 6, 2016.  President and CEO, Andrew Morris, along with Company management, will host a conference call on Tuesday, December 6, 2016 at 5:30 p.m. ET to review financial results and discuss business developments for the period.

Conference Call Details:

Date:

Tuesday December 6, 2016

Time:

5:30 p.m. ET

Live Call:

1-888-231-8191 (Canada and the United States)

Conference ID:

25339014

Webcast:

Here >>

An archived copy of the conference call will be available for 90 days on the Company website at here >> and also at here >>

Detailed financial statements and the management’s discussion and analysis (MD&A) will also be made available on the Company website at www.sqidiagnostics.com and at www.sedar.com.

For more information, please contact:

Chief Executive Officer
Andrew Morris
416.674.9500 ext. 229
amorris@sqidiagnostics.com

Vice President of Finance
Patricia Lie
416.674.9500 ext. 277
plie@sqidiagnostics.com

About SQI Diagnostics

SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human error, and provides excellent data quality. For more information, please visit sqidiagnostics.com.

Forward-looking Statements

This press release contains certain words and statements, which may constitute “forward-looking statements” within the meaning of applicable securities laws.  Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties detailed in the Company’s ongoing filings with the securities regulatory authorities, available to the public at www.sedar.com.  Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE SQI Diagnostics Inc.

Chief Executive Officer, Andrew Morris, 416.674.9500 ext. 229, amorris@sqidiagnostics.com; Vice President of Finance, Patricia Lie, 416.674.9500 ext. 277, plie@sqidiagnostics.comCopyright CNW Group 2016

About SmallCapPower.com

SmallCapPower.com (SCP) is the industry’s most trusted resource for small cap stocks, offering unprecedented access to the research and tools you need to help uncover the next big thing.

Disclosure

Except for the historical information presented herein, matters discussed in this document contain forward- looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Ubika Research and www.smallcappower.com (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.

Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.

For full disclosure please visit Here >>

For additional information contact:

Mark Thorburn- Manager, Media Relations
Email: mark@smallcappower.com
Phone: 416.646.1941